Discussion Board


Registration is recommended, but not required, to use the Nephrology On-Demand Discussion Board.


Welcome Guest 

Show/Hide Header

Welcome Guest, please login or register.

Pages: [1]
 ReplyRSS feed   
Author Topic: New chemo drugs and their renal toxicities
Guest

Posts: 175
Permalink
Post New chemo drugs and their renal toxicities
on: October 26, 2012, 10:03
Quote

One of the chemotherapy regimen for non-small cell lung ca is – Carboplatin, Bevacizumab and Pemetrexed in combination. I saw a patient in my clinic who came for evaluation of CKD 3 and is on the above combination

Thought I should share the renal manifestations:-

Carboplatin-- need to watch for tubular dysfunction (Magnesium, Potassium wasting)

Bevacizumab-- it is VEGF inhibitor-- need to closely monitor proteinuria and Hypertension -- if worsening noted--- suggest increasing wash out period-- or using alternative agent.

Pemetrexed—it is folate antagonist--careful watch of creatinine clearance is mandated-- patients current creatinine clearance is 43.8 ( as per manufacturer instructions-- a dose is not studied for creatinine clearance less than 45)-- case reports showing Acute tubular necrosis, Acute interstitial nephritis, peripheral edema, Nephrogenic DI, Renal tubular acidosis have been published in literature.

Nirav Jasani
Renal fellow

Quick Reply:


Enter Security Code: (required)
Pages: [1]
 ReplyRSS feed   
Mingle Forum by cartpauj
Version: 1.0.34 ; Page loaded in: 0.025 seconds.


Share
  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription